Takeda lays off more than half of Ariad’s US staff
March 31, 2017Medical Communications Ariad Pharmaceuticals, Takeda
Takeda acquired Ariad Pharmaceuticals at the beginning on the year for $5.2 billion, a price many thought was relatively high …
Top Ten most popular articles on Pharmafile.com this week
March 31, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten
It’s the end of the week, and the headlines were populated with stand-out stories that proved popular with our readers. …
FDA approves first-ever atopic dermatitis biologic treatment
March 31, 2017Medical Communications, Sales and Marketing Dupixent, Regeneron, Sanofi, atopic dermatitis, biologic
Sanofi and Regeneron’s Dupixent (dupilumab) has become the first biologic medicine to be approved by the FDA for the treatment …
AstraZeneca ends month with two pieces of news
March 31, 2017Medical Communications, Sales and Marketing AstraZeneca, Tagrisso, TerSera Therapeutics, Zoladex
AstraZeneca has ended the month with more positive news on Tagrisso, that had previously been approved in China under its …
Changing levels of investment in UK drug discovery
March 31, 2017Medical Communications, Research and Development ABPI, drug discovery, report
Key drug discovery investment trends
US and UK partnership to fund the fight against superbugs
March 31, 2017Medical Communications, Research and Development CARB-X, Wellcome Trust
The cross-Atlantic partnership CARB-X, Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator, has announced that it would be funding 11 biotech companies …
Takeda names new President of Europe and Canada Business Unit
March 31, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment
Takeda has named Giles Platford as its new President of Europe and Canada (EUCAN) Business Unit as of 1 April, …
Insider Interview: ABPI’s Paul Catchpole discusses NICE’s new fast-track appraisal system
March 30, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Insider Interview, NICE, Paul Catchpole, fast track
Paul Catchpole, Value and Access Director at the Association of the British Pharmaceutical Industry (ABPI), gives his thoughts on the …
Trump’s FDA pick vows to sever past pharma ties to avoid partisanship
March 30, 2017Medical Communications, Sales and Marketing FDA, Scott Gottlieb, Trump
After much speculation, Donald Trump recently announced his top pick for Commissioner of the FDA as Dr Scott Gottlieb. Gottlieb …
Mylan’s generic of best-selling GSK drug delayed by FDA
March 30, 2017Sales and Marketing Advair, GSK, Mylan
Mylan’s plan to bring its generic competitor to GSK’s best-selling respiratory drug, Advair, has hit a major snag after it …
First treatment for form of MS approved by FDA
March 30, 2017Sales and Marketing Biogen, Genentech, MS, Roche
In big news for sufferers of MS and the company that developed the drug, Roche subsidiary Genetech, the FDA has …
Novartis investigational CAR-T therapy gets FDA priority review
March 30, 2017Sales and Marketing CTL019, FDA, Novartis, leukaemia
Novartis’ investigational chimeric antigen receptor T cell (CAR-T) therapy CTL019 (tisagenlecleucel-T) has been awarded has been awarded priority review by …
Women are 77% of NHS workforce but occupy only 41% board positions
March 29, 2017Medical Communications NHS
A new report, entitled Women on NHS board: 50:50 by 2020, found that women occupied only 41% of board positions …
The April 2017 edition of Pharmafocus is available to read online now!
March 29, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, Pharmafocus new issue
From industry reaction to NICE’s new regulatory guidelines to the rising threat of counterfeit medicine, you can read all the …
Replica reproductive tract could aid drug trials
March 29, 2017Research and Development Woodruff lab
If most people were asked whether they had heard of a scandal in the pharmaceutical industry, the drug that would …
New drug therapy ‘reverses’ diabetes in mice
March 29, 2017Research and Development diabetes
A team of researchers at the University of California, San Diego (UCSD) have developed a drug therapy which has shown …
Breakthrough eczema drug given FDA approval
March 29, 2017Research and Development, Sales and Marketing Dupixent, Regeneron, Sanofi
Regeneron and Sanofi have received approval for its eczema treatment, Dupixent, by the FDA. The treatment will be the first …
Cuts to prescriptions aims to save £128 million annually
March 28, 2017Medical Communications, Research and Development NHS England, prescription
NHS England has identified 10 items that it believes can cut £128 million from its yearly bill. The 10 items …
Alexion leadership uncertainty ends as ex-Baxalta CEO steps in
March 28, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alexion, CEO
Alexion had been left in leadership limbo for the beginning of the year, as former CEO and CFO left under …
Renowned scientist Owen N. Witte joins Kite Pharma Board of Directors
March 28, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Kite Pharma has revealed the addition of celebrated bioscientist and researcher Dr Owen N. Witte to its Board of Directors, …
Latest content
New CCO Ogburn joins Cori Clinical
Claris reports visual acuity gains with experimental LSCD treatment
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics
